Your browser doesn't support javascript.
loading
Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
Pandit, R; Cianci, D; Ter Hark, S E; Winter-van Rossum, I; Ebdrup, B H; Broberg, B V; Garcia-Portilla, M P; Bobes, J; Vinkers, C H; Kahn, R S; Guloksuz, S; Huitema, A D R; Luykx, J J.
Affiliation
  • Pandit R; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Cianci D; Department of Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • Ter Hark SE; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Winter-van Rossum I; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Ebdrup BH; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Broberg BV; Centre for Neuropsychiatric Schizophrenia Research, CNSR & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark.
  • Garcia-Portilla MP; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bobes J; Centre for Neuropsychiatric Schizophrenia Research, CNSR & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark.
  • Vinkers CH; Department of Psychiatry and CIBERSAM, University of Oviedo, Oviedo, Spain.
  • Kahn RS; Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Guloksuz S; Department of Psychiatry and CIBERSAM, University of Oviedo, Oviedo, Spain.
  • Huitema ADR; Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Luykx JJ; Department of Psychiatry, Amsterdam UMC (location VUmc), Amsterdam, the Netherlands.
Acta Psychiatr Scand ; 140(3): 283-290, 2019 09.
Article in En | MEDLINE | ID: mdl-31323113
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents / Weight Gain / Amisulpride Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Acta Psychiatr Scand Year: 2019 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents / Weight Gain / Amisulpride Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Acta Psychiatr Scand Year: 2019 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos